AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1970960 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release formulation (500 mg theophylline)
Number of subjects: 6
Study 394795 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen 5 mg qds
Number of subjects: 40
Study 394795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 29165018 — intervention group
Group type: COMPARATOR
Intervention: Pedometer only (PED)
Number of subjects: 170
Study 29165018 — intervention group
Group type: COMPARATOR
Intervention: Individually tailored, Internet‐mediated pedometer (TI‐PED)
Number of subjects: 170
Study 28887388 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline 400 mg intravenous followed by 400 mg oral daily for 4 days
Number of subjects: 16
Study 28887388 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 16
Study 26513121 — intervention group
Group type: EXPERIMENTAL
Intervention: Allele variants of the serotonin transporter gene (5‐HTT)
Number of subjects: 99
Study 26513121 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation of the promoter region of the serotonin transporter gene
Number of subjects: 99
Study 23692998 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiders
Number of subjects: 0
Study 23692998 — intervention group
Group type: COMPARATOR
Intervention: Non-threatening objects (balls and ladybugs)
Number of subjects: 0
Study 21458191 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin daily for 5 years
Number of subjects: 18348
Study 21458191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18348
Study 21458191 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin daily
Number of subjects: 18348
Study 19353539 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g fenugreek fiber
Number of subjects: 18
Study 19353539 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 g fenugreek fiber
Number of subjects: 18
Study 19353539 — intervention group
Group type: COMPARATOR
Intervention: 0 g fenugreek fiber (control)
Number of subjects: 18
Study 17509194 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole 7.5 mg
Number of subjects: 179
Study 17509194 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole 5 mg
Number of subjects: 179
Study 17509194 — intervention group
Group type: COMPARATOR
Intervention: Letrozole 2.5 mg
Number of subjects: 179
Study 14980901 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin 0.3 micro g/kg
Number of subjects: 100
Study 14980901 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 100
Study 11391747 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine followed by bromocriptine + levodopa (group B/D)
Number of subjects: 60
Study 11391747 — intervention group
Group type: COMPARATOR
Intervention: Levodopa alone (group D)
Number of subjects: 60
Study 11391747 — intervention group
Group type: COMPARATOR
Intervention: General French population
Number of subjects: 60
Study 9246141 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic nebulised colistin
Number of subjects: 27
Study 9246141 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic nebulised colistin
Number of subjects: 27
Study 9246141 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotonic nebulised colistin
Number of subjects: 27
Study 8516091 — intervention group
Group type: EXPERIMENTAL
Intervention: Calf lung surfactant extract (CLSE) administered at birth
Number of subjects: 1248
Study 8516091 — intervention group
Group type: COMPARATOR
Intervention: Early treatment (control group)
Number of subjects: 1248
Study 3436153 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide/amiloride (25 mg/2.5 mg)
Number of subjects: 60
Study 3436153 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide/triamterene (25 mg/50 mg)
Number of subjects: 60
Study 31706868 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep venous thrombosis
Number of subjects: 3000000
Study 31706868 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary embolism
Number of subjects: 3000000
Study 28918547 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive step goal + reward intervention via smartphone app (Just Walk)
Number of subjects: 20
Study 28969948 — intervention group
Group type: COMPARATOR
Intervention: Normal-weight patients (BMI ≤ 24.99)
Number of subjects: 256
Study 28969948 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients (BMI ≥ 30)
Number of subjects: 256
Study 28969948 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight patients (BMI 25-29.99)
Number of subjects: 256
Study 26537944 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g pure whey protein isolate (L)
Number of subjects: 18
Study 26537944 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 g pure whey protein isolate (H)
Number of subjects: 18
Study 26537944 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 18
Study 23143590 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi intervention (3 × 1.5 h supervised sessions per week for 12 weeks)
Number of subjects: 41
Study 21354547 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n = 40)
Number of subjects: 80
Study 21354547 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 40)
Number of subjects: 80
Study 18440484 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-down position (P1 group)
Number of subjects: 144
Study 18440484 — intervention group
Group type: COMPARATOR
Intervention: Seated position (P0 group)
Number of subjects: 144
Study 18440484 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (P0 and P1)
Number of subjects: 144
Study 16563324 — intervention group
Group type: EXPERIMENTAL
Intervention: VIMA group (5% sevoflurane and 60% N2O in oxygen for induction; 2% sevoflurane and 60% N2O in oxygen for maintenance)
Number of subjects: 20
Study 16563324 — intervention group
Group type: COMPARATOR
Intervention: TIVA group (propofol 2.0 mg/kg intravenously by bolus injection and fentanyl 2 microg/kg for induction; propofol 5 mg/kg per hour for maintenance)
Number of subjects: 20
Study 14640847 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine conditions
Number of subjects: 0
Study 14640847 — intervention group
Group type: COMPARATOR
Intervention: Nonroutine conditions
Number of subjects: 0
Study 14640847 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed participants (Study 3)
Number of subjects: 0
Study 14640847 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacationers and kibbutz members (Studies 5 and 6)
Number of subjects: 0
Study 11104482 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable airbed
Number of subjects: 90
Study 11104482 — intervention group
Group type: COMPARATOR
Intervention: Innerspring mattresses
Number of subjects: 90
Study 9074373 — intervention group
Group type: EXPERIMENTAL
Intervention: Single catheter technique of hepatic venous isolation and charcoal hemoperfusion (HVI‐CHP)
Number of subjects: 16
Study 9074373 — intervention group
Group type: COMPARATOR
Intervention: Double‐balloon technique (group A)
Number of subjects: 16
Study 9074373 — intervention group
Group type: EXPERIMENTAL
Intervention: Single catheter technique (group B)
Number of subjects: 16
Study 8457045 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximetry monitoring
Number of subjects: 20802
Study 8457045 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pulse oximetry monitoring)
Number of subjects: 20802
Study 3520160 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of glucose, insulin, and potassium
Number of subjects: 0
Study 31036115 — intervention group
Group type: EXPERIMENTAL
Intervention: Unibody bifurcated endovascular stent-graft repair
Number of subjects: 80
Study 31036115 — intervention group
Group type: COMPARATOR
Intervention: Conventional open surgical repair
Number of subjects: 80
Study 26830631 — intervention group
Group type: EXPERIMENTAL
Intervention: Church-based health-empowerment program
Number of subjects: 70
Study 26830631 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 70
Study 26002004 — intervention group
Group type: EXPERIMENTAL
Intervention: Microincision (2.2 mm) phacoemulsification
Number of subjects: 50
Study 26002004 — intervention group
Group type: COMPARATOR
Intervention: Standard (2.75 mm) phacoemulsification
Number of subjects: 50
Study 26002004 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 50
Study 23341572 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 45
Study 23341572 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 45
Study 23341572 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet + Exercise
Number of subjects: 45
Study 23341572 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss (overall analysis)
Number of subjects: 45
Study 23341572 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised clustering
Number of subjects: 45
Study 23341572 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 45
Study 21884320 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 0
Study 21884320 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 19302581 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate 7.5 mg/month
Number of subjects: 14
Study 19302581 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate 11.25 mg every 3 months
Number of subjects: 14
Study 19302581 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate 22.5 mg every 3 months
Number of subjects: 14
Study 19302581 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (7.5 mg, 11.25 mg, 22.5 mg)
Number of subjects: 14
Study 17352633 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser needle acupuncture at Neiguan (PC6) with laser irradiation (36.8 kJ/cm(2))
Number of subjects: 45
Study 17352633 — intervention group
Group type: COMPARATOR
Intervention: Placebo group with no laser irradiation
Number of subjects: 45
Study 15257847 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored follow-up intervention (mailed computer-tailored health messages and telephone counseling)
Number of subjects: 511
Study 15257847 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 511
Study 15257847 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 511
Study 11407567 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported Conversation for Adults with Aphasia (SCA) training
Number of subjects: 40
Study 11407567 — intervention group
Group type: COMPARATOR
Intervention: Control group (untrained volunteers)
Number of subjects: 40
Study 9814458 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium therapy
Number of subjects: 53
Study 7711132 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin + Metronidazole
Number of subjects: 76
Study 7711132 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 76
Study 2645824 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers (metoprolol and propranolol)
Number of subjects: 58
Study 2645824 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 58
Study 2645824 — intervention group
Group type: COMPARATOR
Intervention: Baseline (no treatment)
Number of subjects: 58
Study 2645824 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up (after washout)
Number of subjects: 58
Study 788760 — intervention group
Group type: EXPERIMENTAL
Intervention: Brolitene (1200 mg per day, 6 tablets)
Number of subjects: 27
Study 788760 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 27
Study 30566641 — intervention group
Group type: EXPERIMENTAL
Intervention: Water supplementation (1.5 L daily for 6 weeks)
Number of subjects: 31
Study 28660719 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 phone-based lifestyle intervention sessions
Number of subjects: 200
Study 28660719 — intervention group
Group type: COMPARATOR
Intervention: 16 educational mailings
Number of subjects: 200
Study 28660719 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants not using insulin in the intervention group
Number of subjects: 200
Study 28660719 — intervention group
Group type: COMPARATOR
Intervention: Participants not using insulin in the control group
Number of subjects: 200
Study 25971243 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine plus sertraline
Number of subjects: 259
Study 25971243 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine plus placebo
Number of subjects: 259
Study 22898451 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured walking intervention (10-week program with pedometer-defined walks, fitness-tailored walking load)
Number of subjects: 432
Study 22898451 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition (no intervention)
Number of subjects: 432
Study 21470595 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasally administered oxytocin
Number of subjects: 42
Study 21470595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 19466647 — intervention group
Group type: EXPERIMENTAL
Intervention: Go Sun Smart (GSS) campaign
Number of subjects: 0
Study 18182864 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse presence program (experimental group)
Number of subjects: 39
Study 18182864 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 39
Study 15126990 — intervention group
Group type: EXPERIMENTAL
Intervention: Laronidase (100 U/kg, 0.58 mg/kg) administered intravenously weekly for 26 weeks
Number of subjects: 45
Study 15126990 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered intravenously weekly for 26 weeks
Number of subjects: 45
Study 11715612 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive tracheostomy procedures
Number of subjects: 20000
Study 11715612 — intervention group
Group type: COMPARATOR
Intervention: Conventional operative tracheostomy
Number of subjects: 20000
Study 11715612 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive procedures
Number of subjects: 20000
Study 9143566 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous gentamicin and chloramphenicol
Number of subjects: 114
Study 9143566 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic treatment
Number of subjects: 114
Study 7706587 — intervention group
Group type: COMPARATOR
Intervention: Isocal HN
Number of subjects: 10
Study 7706587 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultracal
Number of subjects: 10
Study 3240302 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk supplemented with 1 mmol NaH2PO4 per 100 ml
Number of subjects: 125
Study 3240302 — intervention group
Group type: COMPARATOR
Intervention: Native human milk
Number of subjects: 125
Study 3240302 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk supplemented with NaH2PO4
Number of subjects: 125
Study 3240302 — intervention group
Group type: EXPERIMENTAL
Intervention: Both feeding groups
Number of subjects: 125
Study 3240302 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk
Number of subjects: 125
Study 31578760 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention effect estimates
Number of subjects: 0
Study 31578760 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard deviation estimates
Number of subjects: 0
Study 31578760 — intervention group
Group type: EXPERIMENTAL
Intervention: Confidence intervals
Number of subjects: 0
Study 31578760 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical power
Number of subjects: 0
Study 31578760 — intervention group
Group type: EXPERIMENTAL
Intervention: Probability of non-compliance
Number of subjects: 0
Study 28389125 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of antiplatelet, statin and blood pressure lowering drugs
Number of subjects: 15140
Study 28389125 — intervention group
Group type: EXPERIMENTAL
Intervention: Control in ≥four of five guideline levels of risk factors
Number of subjects: 15140
Study 28389125 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription of BP-lowering drugs and statins at discharge
Number of subjects: 15140
Study 28389125 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower income
Number of subjects: 15140
Study 25657051 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive individual counselling delivered by a practice nurse with 12 weeks of open-label varenicline
Number of subjects: 272
Study 25657051 — intervention group
Group type: COMPARATOR
Intervention: Brief advice delivered by a general practitioner with 12 weeks of open-label varenicline
Number of subjects: 272
Study 23856511 — intervention group
Group type: EXPERIMENTAL
Intervention: BUD/FORM 320/9 μg bid + TIO 18 μg qd
Number of subjects: 659
Study 23856511 — intervention group
Group type: EXPERIMENTAL
Intervention: BUD/FORM + TIO
Number of subjects: 659
Study 23856511 — intervention group
Group type: COMPARATOR
Intervention: PBO + TIO
Number of subjects: 659
Study 21979186 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedicle coagulation
Number of subjects: 120
Study 21979186 — intervention group
Group type: COMPARATOR
Intervention: Pedicle ligation
Number of subjects: 120
Study 18667842 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical methimazole 5% applied once daily for 6 weeks
Number of subjects: 20
Study 18667842 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical methimazole 5%
Number of subjects: 20
Study 18667842 — intervention group
Group type: COMPARATOR
Intervention: Oral methimazole 5 mg tablet
Number of subjects: 20
Study 19363280 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg daily for 20 days
Number of subjects: 16
Study 19363280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 14766711 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil 10-15 mg h(-1) continuous i.v. infusion for 3 days before surgery and until adrenal gland removal
Number of subjects: 18
Study 14766711 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil
Number of subjects: 18
Study 11332444 — intervention group
Group type: EXPERIMENTAL
Intervention: NIAAA screening strategy (combining alcohol consumption questions and CAGE questionnaire)
Number of subjects: 395
Study 9387067 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG with enoximone (used in all but 5 patients)
Number of subjects: 352
Study 9387067 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG with intra-aortic balloon pump (used in 9 cases)
Number of subjects: 352
Study 8189180 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised assessment
Number of subjects: 92
Study 8189180 — intervention group
Group type: COMPARATOR
Intervention: Human interviewer assessment
Number of subjects: 92
Study 2888693 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine
Number of subjects: 20
Study 2888693 — intervention group
Group type: COMPARATOR
Intervention: ranitidine
Number of subjects: 20
Study 31626100 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (topical anesthesia of the throat and regional anesthesia of the scalp)
Number of subjects: 0
Study 31626100 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia only (Control Group C)
Number of subjects: 0
Study 31626100 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (Group L)
Number of subjects: 0
Study 28704847 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 136
Study 28704847 — intervention group
Group type: COMPARATOR
Intervention: Standard postcesarean wound care (WC)
Number of subjects: 136
Study 26142266 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug therapy optimization
Number of subjects: 150
Study 24443830 — intervention group
Group type: EXPERIMENTAL
Intervention: IDeg+Lira
Number of subjects: 177
Study 24443830 — intervention group
Group type: COMPARATOR
Intervention: IDeg+IAsp
Number of subjects: 177
Study 22989378 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab (NAT)
Number of subjects: 23
Study 22989378 — intervention group
Group type: COMPARATOR
Intervention: Glatiramer acetate (GA)
Number of subjects: 23
Study 20214337 — intervention group
Group type: EXPERIMENTAL
Intervention: CPSG 5 g per day for 2 weeks
Number of subjects: 80
Study 20214337 — intervention group
Group type: COMPARATOR
Intervention: Starch granule (control) for 2 weeks
Number of subjects: 80
Study 17457013 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg/day)
Number of subjects: 24
Study 17457013 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 24
Study 15105217 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 1200 mg
Number of subjects: 50
Study 15105217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 15105217 — intervention group
Group type: COMPARATOR
Intervention: Gabapentin 1200 mg and Placebo
Number of subjects: 50
Study 11298484 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream (Aldara)
Number of subjects: 0
Study 9749654 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual drug therapy + spa therapy (6 days a week for 3 consecutive weeks)
Number of subjects: 224
Study 9749654 — intervention group
Group type: COMPARATOR
Intervention: Usual drug therapy
Number of subjects: 224
Study 7835381 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan 6 mg
Number of subjects: 0
Study 7835381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3067695 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 206
Study 3067695 — intervention group
Group type: COMPARATOR
Intervention: Control (no Vitamin A supplementation)
Number of subjects: 206
Study 31696347 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinding and randomization
Number of subjects: 0
Study 30670268 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemon Balm essential oil
Number of subjects: 49
Study 30670268 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender essential oil
Number of subjects: 49
Study 30670268 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Sunflower oil)
Number of subjects: 49
Study 27404165 — intervention group
Group type: EXPERIMENTAL
Intervention: Engineered skin substitutes (ESS)
Number of subjects: 15
Study 27404165 — intervention group
Group type: COMPARATOR
Intervention: Split-thickness autograft (AG)
Number of subjects: 15